United Therapeutics enters $1B accelerated share repurchase agreements with Citibank

UNITED THERAPEUTICS Corp

Two ASR agreements with Citibank: $500M uncollared and $500M collared; total upfront payment $1B due Aug 4, 2025.
Uncollared ASR: initial delivery ~1.27M shares (75% of expected); final settlement expected Q4 2025 based on VWAP less discount.
Collared ASR: initial delivery ~850K shares (50% of expected); additional delivery after hedging; final settlement expected Q1 2026 with collar.
At July 30, 2025, company had ~45.2M shares outstanding; CEO cites confidence in intrinsic value and cash flow generation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.